Anti-CXCR4 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CXCR4 antibody, covering 2015-03-06 to 2015-03-06. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers [Phase 1]